tiprankstipranks
Advertisement
Advertisement
Three Years of War Changed What Governments Buy. One Player is Already Winning Contracts (NASDAQ: MDWD)
PremiumTipRanks NewswireThree Years of War Changed What Governments Buy. One Player is Already Winning Contracts (NASDAQ: MDWD)
1M ago
Tenax Therapeutics highlights key Phase 3 LEVEL trial
Premium
Company Announcements
Tenax Therapeutics highlights key Phase 3 LEVEL trial
1M ago
Tenax and Orion Secure Long-Term Levosimendan Supply Deal
Premium
Company Announcements
Tenax and Orion Secure Long-Term Levosimendan Supply Deal
1M ago
Tenax Therapeutics Announces Results of 2026 Annual Meeting
PremiumCompany AnnouncementsTenax Therapeutics Announces Results of 2026 Annual Meeting
2M ago
Tenax Therapeutics: Buy Rating Reiterated with $27 Price Target Unchanged on Compelling Phase 3 Opportunity
Premium
Ratings
Tenax Therapeutics: Buy Rating Reiterated with $27 Price Target Unchanged on Compelling Phase 3 Opportunity
3M ago
Tenax Therapeutics reports Q1 EPS (35c), consensus (40c)
Premium
The Fly
Tenax Therapeutics reports Q1 EPS (35c), consensus (40c)
3M ago
DraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
PremiumThe FlyDraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
5M ago
Cantor starts Tenax at Overweight into Phase 3 readout
Premium
The Fly
Cantor starts Tenax at Overweight into Phase 3 readout
5M ago
Tenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Tenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100